NIPH Clinical Trials Search

JAPANESE
UMIN ID: UMIN000034206

Registered date:21/09/2018

Clinical outcome of trabectedin in Japanese patients with soft tissue sarcoma; JMOG multicenter study

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedMalignant soft tissue tumor
Date of first enrollment2017/09/22
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeProgressive-free survival
Secondary OutcomeSurvival Side effect (CTCAE)

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients who are not treated in the registered institutions of Japanese Musculoskeletal Oncology Group will be excluded from this study.

Related Information

Contact

public contact
Name Hiroshi Kobayashi
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo Japan 113-8655
Telephone 03-3815-5411
E-mail hkobayashi-tky@umin.ac.jp
Affiliation The University of Tokyo Hospital Orthopaedic department
scientific contact
Name Sakae Tanaka
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo Japan
Telephone 03-3815-5411
E-mail tanakas-ort@h.u-tokyo.ac.jp
Affiliation The University of Tokyo Hospital Orthopaedic department